http://www.standardmedicalsystems.com/blog/rss/feedsStandard Medical Systems is a national distributor of novel biomedical devices, and supplies, that are best in class, and are made by top global firmsMon, 27 Apr 2026 13:12:10 -0700http://www.standardmedicalsystems.com/blog/post/microsure-all-purpose-cleaner-and-disinfectanthttp://www.standardmedicalsystems.com/blog/post/microsure-all-purpose-cleaner-and-disinfectant microSURE All Purpose Cleaner and Disinfectant EPA Company No. 95990 microSURE All Purpose Cleaner and Disinfectant is a one-step Ready-to-Use (RTU) disinfectant cleaner and odor neutralizer designed for general cleaning and disinfecting of hard, non-porous, inanimate surfaces. microSURE All Purpose Cleaner and Disinfectant is Virucidal, Germicidal, Bactericidal, Fungicidal and eliminates Mold & Mildew while it protects against harmful pathogens It's proprietary formula creates a micro crystalline-like structure forming a covalent bond to almost any surface and is effective not only at application but continues killing harmful pathogens for weeks and months longer than typical disinfectants.Sun, 12 Jul 2020 15:00:00 -0700http://www.standardmedicalsystems.com/blog/post/to-wear-or-not-to-wear-a-mask--that-is-the-question--by-meyer-greenbaum-july-3-2020http://www.standardmedicalsystems.com/blog/post/to-wear-or-not-to-wear-a-mask--that-is-the-question--by-meyer-greenbaum-july-3-2020If you would have told me 6 months ago that I would be fined for walking on the street in Los Angeles without a mask, I would have assumed that you had just finished smoking whatever sample you had just been given at your local dispensary..Over the last few months of our new insanity, our dutiful citizens have fashioned every imaginable permutation of face covering thought possible. every color, material, brand and size.And yet...Almost none of them work. Know why? Because for a mask to work, you actually have to wear it.Dangling under your chin? Not really... Hanging off your ear? Please! And that nose peeking over the edge so you can breathe is just asking for trouble.So what's one to do?Earlier this year, just as Covid-19 was grabbing headlines, a business associate of mine called me about a new mask concept that he was involved in and wanted me to take a look at. At Cutting Edge, we see scores of new products, solutions and inventions in the healthcare space, so it takes a lot to get me interested.It was a product called the Savage Shield, and the minute I tried it on, I understood his excitement.I love the feeling of waking up in the morning, brushing my teeth and starting off the day with minty fresh breath. By midday however, after a coffee and some breakfast, wearing a mask can be difficult for anyone. No one should have to smell the tuna salad sandwich they just ate. It's inhumane!Now that's just me, who has to intermittently wear a mask. Imagine what our front line healthcare workers have to deal with during their long shifts. The thought is unbearable.So what was so special about the Savage Shield?It has a patented design that separates the nasal chamber from the oral chamber. Simple? Brilliant! No more cycling the Carbon Dioxide that you are exhaling with the Oxygen that you are inhaling. No more muffled communication. No more fogging of your glasses or goggles.I have been wearing it every day since. It doesn't lose its shape. Maintains a tight yet comfortable silicone seal and best of all, it's a one time buy that is easily cleaned and sanitized and comes with replacement filters that have a BFE (Bacterial Filtration Efficiency) of 98It is already revolutionizing the way healthcare workers are thinking about facial protection. No N95 masks available? No problem.Thu, 02 Jul 2020 11:30:00 -0700http://www.standardmedicalsystems.com/blog/post/journal-of-vascular-and-interventional-radiologyhttp://www.standardmedicalsystems.com/blog/post/journal-of-vascular-and-interventional-radiologyJournal of Vascular and Interventional Radiology.https://www.jvir.org/article/S1051-0443(09)00300-5/fulltext Mon, 13 Aug 2018 06:13:00 -0700http://www.standardmedicalsystems.com/blog/post/intraoperative-neuromonitoring-market-worth-36-billion-by-2025http://www.standardmedicalsystems.com/blog/post/intraoperative-neuromonitoring-market-worth-36-billion-by-2025February 2017 | Report Format: Electronic (PDF)The global Intraoperative Neuromonitoring (IONM) market is expected to reach USD 3.6 billion by 2025, based on a new report by Grand View Research, Inc. The intraoperative neuromonitoring market is anticipated to witness significant growth in the forecast period, which can be attributed to the hospitals adopting intraoperative monitoring in a wide spectrum of surgeries.Major surgeries pose a risk to the nervous system that necessitates neuromonitoring. This has resulted in growing popularity of intraoperative neuromonitoring amongst surgical teams, surgeons, and hospitals. It results in reduced cases of revision surgeries, postoperative complications, and permanent impairment.Industry players are acquiring smaller companies to expand their product offerings and geographical presence. For instance, in June 2016, Biotronic NeuroNetwork, LLC, headquartered in Michigan, was acquired by NuVasive, Inc., in a transaction worth USD 98 million. To request a sample copy or view summary of this report, click the link below: http://www.grandviewresearch.com/industry-analysis/intraoperative-neuromonitoring-market Further key findings from the study suggest:Insourced IONM dominated the market in 2015, which is attributed to the rising number of surgeries and emphasis on patient during the procedures. IONM is utilized to minimize the neurological morbidity caused by operative manipulations. This offers detection of injuries during the operation and minimizes the risk of permanent nerve damage. Hospitals have adopted intraoperative monitoring and have trained technologists, who are supervised by neurologists and physiologists during the procedures.Outsourced IONM is also gaining popularity and is expected to grow at a rapid rate over the forecast period Hospitals and healthcare centers choose to outsource their IONM needs due to benefits such as cost-efficiency and availability of focused service providers.Geographically, North America dominated the industry in 2015 and is expected to maintain its position during the forecast period. It is accepted as a standard of care by the medical community in this region due to its benefits. New neurosurgeons and orthopedic surgeons are being trained to adopt this technique during procedures.Asia Pacific is anticipated to observe the fastest growth over the coming years. Rising number of surgeries, developing economies, growing capacity of patients to bear expenses, and presence of a large patient pool are few factors contributing to this growth.Some of the key industry contributors are Biotronic NeuroNetwork, LLC; Medtronic; Accurate Monitoring; NuVasive Inc.; Natus Medical Incorporated; SpecialtyCare; Sentient Medical Systems; and NeuroMonitoring Technologies, Inc.Grand View Research has segmented the intraoperative neuromonitoring (IONM) market by type and region:IONM Market Type Outlook (Market Revenue in USD Million, 2014 - 2025)Insourced IONMOutsourced IONMIONM Market Regional Outlook (Market Revenue in USD Million, 2014 - 2025)North AmericaU.S.CanadaEuropeGermanyUKAsia PacificJapanChinaLatin AmericaBrazilMexicoMEASouth AfricaFri, 10 Aug 2018 19:42:00 -0700http://www.standardmedicalsystems.com/blog/post/true-botanic-inc-truebotanichttp://www.standardmedicalsystems.com/blog/post/true-botanic-inc-truebotanicA study on autism spectrum that was led by the director of pediatric neurology at Jerusalem’s Shaare Zedek Hospital, Dr. Adi Aran, who treated the 60 children CBD and 80% of children saw improvement.#CBD #Cannabidiol #cbdoil #autismspectrum #autistimleafly.com/news/health/reWed, 08 Aug 2018 11:45:00 -0700http://www.standardmedicalsystems.com/blog/post/medical-marijuana-sales-decline-continues-in-colorado-as-recreational-weed-disrupts-market-benzingahttp://www.standardmedicalsystems.com/blog/post/medical-marijuana-sales-decline-continues-in-colorado-as-recreational-weed-disrupts-market-benzingaMedical marijuana sales continue to slide in Colorado. For the first half of 2018, revenue fell 21 percent year-over-year to $165.8 million. Recreational sales rose 14 percent to $573 million. Total combined sales rose by 4 percent to reach $739 million, versus $710 million in the first half of 2017. In June alone, medical marijuana sales dropped by 30 percent year-over-year to $25.3 million, while recreational cannabis sales advanced 14 percent to $99.4 million. Rec Market 'Disruptive'The Cannabis Branding Battle AheadForbes MagazineIncreasingly higher stakes are at play as cannabis marketers determine how best to build their brands.New York to allow medical marijuana as substitute to opioidsABC NewsNew York state is now allowing anyone prescribed an opioid to request medical marijuana instead.Legalizing weed is the right move for New York, the state’s health department saysThe Verge‘It has become less a question of whether to legalize but how to do so responsibly.Jefferson University offers medical marijuana grad programsABC NewsThomas Jefferson University in Philadelphia will be offering graduate-level certificate program in medical marijuana.Mon, 16 Jul 2018 13:49:00 -0700http://www.standardmedicalsystems.com/blog/post/explore-the-world-of-copd-insiderhttp://www.standardmedicalsystems.com/blog/post/explore-the-world-of-copd-insiderCan’t get enough information about COPD?At COPD insider, industry experts and those on the front lines of patient care come together to exchange ideas and insights to drive the transformation of COPD care.The biggest challenges deconstructed. Practical solutions for the entire treatment team. The latest clinical strategies. They all live right here at COPD insider.Here’s a sampling of what you can find:Driving value with home NIV: Discover how you could save your organization millions Dr. Teofilo Lee-Chiong, chief Pulmonologist and Chief Medical Liaison at Philip, discusses how emerging evidence has reinforced the use of home-based noninvasive ventilation (NIV) to treat patients with chronic hypercapnic COPD Key findings:Reduce the frequencey of exacerbationReduce readmissionsSignificantly improve patients' quality of lifeThree keys to reducing readmissions of your “frequent flyers” Becky Anderson, Respiratory Care Services Manager at Sanford Medical, and Les Duncan Operations Director for Highmark Community and Health services, review keys to reducing readmissions for COPD “frequent flyers” – COPD patients readmitted to the ER time and time again. Insights include the right care team make up and best prctices for communicating and engaging with patients.Fri, 13 Jul 2018 08:19:00 -0700http://www.standardmedicalsystems.com/blog/post/some-facts-about-care-orchestrator-essencehttp://www.standardmedicalsystems.com/blog/post/some-facts-about-care-orchestrator-essencePhilips recently launched Care Orchestrator Essence — a desktop-based solution designed to allow clinicians the ability to interact with therapy data, and quickly locate areas of interest, to support fast and efficient care for sleep apnea and respiratory patients. Below Philips Product Manager Kevin Erdner answers some common questions about this exciting new offering. Q: Why a desktop product? I thought the whole world was connected.While the world is certainly becoming more and more connected, many parts of the world do not have the infrastructure necessary to support cloud-based medical systems. As part of Philip’s vision of improving the lives of 3 billion people a year by the year 2025, CO Essence brings quality healthcare to those areas that are not as connected as we are here. In addition, many of our customers are reluctant to store their patients’ medical data on a cloud-based system out of concern for data breaches. CO Essence fills this gap by providing a solution to meet the basic needs of these customers. Q: What’s the core value provided by CO Essence?Care Orchestrator Essence provides an efficient solution for our customers by providing the basic functions necessary to treat patients with sleep or respiratory care needs. CO Essence is targeted for use by both DME users and physicians providing clinical care, providing a simple user experience to quickly assess patient condition and treatment efficacy. Q: What are the innovations included in CO Essence?CO Essence includes many innovations by utilizing the latest software technology and trends in user experience design. One example of this innovation is the interactive display of patient therapy data. Physicians using CO Essence have the ability to truly interact with their patients’ data; zooming in and out on various graphs, marking areas of interest within the data, and visually comparing one clinical metric to another. This experience allows the physician to quickly assess the efficacy of the patient’s treatment and can make adjustments as necessary. Q: What type of PC is needed to run CO Essence?CO Essence is designed to perform on the Windows operating system. CO Essence will perform adequately on Windows® 7 Service Pack 1 or higher, and a PC with at least a 2 GHz processor, 1 GB of RAM and an 80 Gb hard drive is recommended. Q: What devices does Care Orchestrator Essence support?Care Orchestrator Essence supports the broad portfolio of sleep and respiratory care devices. This includes the 60-Series family of CPAP, BiPAP and ASV device, the DreamStation family of devices, and soon the Trilogy ventilation device. Fri, 13 Jul 2018 07:56:00 -0700http://www.standardmedicalsystems.com/blog/post/take-a-breathhttp://www.standardmedicalsystems.com/blog/post/take-a-breathPerformance of mesh nebulizersTreating patients with COPD effectively can be a challenge. With their ability to literally take a breath acutely impaired, how can we help them get the right dose of inhaled bronchodilators? What kinds of devices might work better?Patients with severe COPD often don’t get the right dose of prescribed medications when they use pMDIs or DPIs. We also know their I:E ratios affect delivered doses from nebulizers, but what isn’t well documented is the impact of inspiratory flow. Given that a wide range of peak inspiratory flows is defined as suboptimal for DPI, we tested the consistency of dosing from a mesh nebulizer over a range of breathing patterns representing COPD patients with suboptimal peak inspiratory flow.How the study was doneSix (6) breathing patterns were observed; five (5) covered a range of patients with severe COPD. The sixth was the test pattern specified in the European Committee for Standardization (CEN) EN 13544-1 nebulizer testing guideline, which was used for comparison of the results to standard test results. A Philips InnoSpire Go mesh nebulizer for this study. What the study suggestedResults were presented at this year’s Respiratory Drug Delivery conference in Tucson. We found that the dose delivered by the mesh nebulizer was reliably independent of peak inspiratory flows over the range of 10–65 L/min. This is in marked contrast to the relationship between flow and dose delivery for many DPI devices. This may have implications when considering treatment, especially for those with severe COPD who may struggle to achieve moderate to high inspiratory flows. The results for the CEN pattern provide a reference to standard nebulizer test methods and support the fact that delivered dose from constant output nebulizers is dependent upon the I:E ratio of the breathing pattern. A conclusionThe dose delivered by the mesh nebulizer was relatively unaffected by peak inhalation flow when tested using simulated breathing patterns with an I:E ratio representative of patients with severe COPD. What might this mean for your patients?Prescribing a mesh nebulizer for certain acute COPD patients may help to ensure that they receive the dose of medication that has been deemed best for their condition. Recap of the poster sessionPoster presented at Respiratory Drug Delivery, April 22-26, Tucson, ArizonaAuthors: John N. Pritchard, Richard Potter and Ross H. M. HatleyRespironics Respiratory Drug Delivery (UK) Ltd., a business of Philips Electronics UK Limited.Fri, 13 Jul 2018 07:53:00 -0700http://www.standardmedicalsystems.com/blog/post/satellite-symposiumhttp://www.standardmedicalsystems.com/blog/post/satellite-symposiumSatellite symposium: noninvasive COPD screening of expiratory flow limitation within home therapySymposium sponsored by Philips RespironicsERCA-JIVD 3rd Joint International Meeting, Lyon, France, March 2018 Tidal expiratory flow (EFL) limitation can occur in COPD patients when they exercise, or in more severe cases, when they aren't exercising - in either case creating what is sometimes descries as a "severe mechanical constraint¹."Recently Peter Calverley and Raffaele L. Dellacà led a symposium to discuss tidal expiratory flow limitation and its effects, how to measure it noninvasively and effectively, and how using ventilators to minimize tidal EFL can produce physiological improvements.Fri, 13 Jul 2018 07:49:00 -0700